195 related articles for article (PubMed ID: 16778799)
1. High frequency of FGFR3 mutations in adenoid seborrheic keratoses.
Hafner C; van Oers JM; Hartmann A; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Vogt T
J Invest Dermatol; 2006 Nov; 126(11):2404-7. PubMed ID: 16778799
[TBL] [Abstract][Full Text] [Related]
2. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
Hafner C; Vogt T; Landthaler M; Müsebeck J
Br J Dermatol; 2008 Jul; 159(1):214-7. PubMed ID: 18503601
[TBL] [Abstract][Full Text] [Related]
3. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
Logié A; Dunois-Lardé C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F
Hum Mol Genet; 2005 May; 14(9):1153-60. PubMed ID: 15772091
[TBL] [Abstract][Full Text] [Related]
4. FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization.
Hafner C; Hartmann A; van Oers JM; Stoehr R; Zwarthoff EC; Hofstaedter F; Landthaler M; Vogt T
Mod Pathol; 2007 Aug; 20(8):895-903. PubMed ID: 17585316
[TBL] [Abstract][Full Text] [Related]
5. FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin.
Hafner C; Hartmann A; Vogt T
J Invest Dermatol; 2007 Jul; 127(7):1572-3. PubMed ID: 17568799
[TBL] [Abstract][Full Text] [Related]
6. FGFR3 mutations in benign skin tumors.
Hafner C; Vogt T; Hartmann A
Cell Cycle; 2006 Dec; 5(23):2723-8. PubMed ID: 17172848
[TBL] [Abstract][Full Text] [Related]
7. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
Hafner C; van Oers JM; Vogt T; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Hartmann A
J Clin Invest; 2006 Aug; 116(8):2201-2207. PubMed ID: 16841094
[TBL] [Abstract][Full Text] [Related]
8. Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors.
Duperret EK; Oh SJ; McNeal A; Prouty SM; Ridky TW
Cell Cycle; 2014; 13(10):1551-9. PubMed ID: 24626198
[TBL] [Abstract][Full Text] [Related]
9. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses.
Hafner C; Hartmann A; Real FX; Hofstaedter F; Landthaler M; Vogt T
J Invest Dermatol; 2007 Aug; 127(8):1883-5. PubMed ID: 17392824
[TBL] [Abstract][Full Text] [Related]
11. FGFR3 and PIK3CA mutations in stucco keratosis and dermatosis papulosa nigra.
Hafner C; Landthaler M; Mentzel T; Vogt T
Br J Dermatol; 2010 Mar; 162(3):508-12. PubMed ID: 19845664
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.
Hernández S; Toll A; Baselga E; Ribé A; Azua-Romeo J; Pujol RM; Real FX
J Invest Dermatol; 2007 Jul; 127(7):1664-6. PubMed ID: 17255960
[TBL] [Abstract][Full Text] [Related]
13. A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans.
Mandinova A; Kolev V; Neel V; Hu B; Stonely W; Lieb J; Wu X; Colli C; Han R; Pazin MJ; Ostano P; Dummer R; Brissette JL; Dotto GP
J Clin Invest; 2009 Oct; 119(10):3127-37. PubMed ID: 19729838
[TBL] [Abstract][Full Text] [Related]
14. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
van Rhijn BW; van Tilborg AA; Lurkin I; Bonaventure J; de Vries A; Thiery JP; van der Kwast TH; Zwarthoff EC; Radvanyi F
Eur J Hum Genet; 2002 Dec; 10(12):819-24. PubMed ID: 12461689
[TBL] [Abstract][Full Text] [Related]
15. Familial seborrhoeic keratosis associated with multiple 'pure reticulated acanthomas' and infundibulocystic basal cell carcinomas.
Agustí Martínez J; Bella-Navarro R; García-García AB; Bueno E; González-Sarmiento R; Navarro L; Sanchez-Sendra B; Revert A; Jordá E; Monteagudo C
Br J Dermatol; 2017 Dec; 177(6):1654-1663. PubMed ID: 28627087
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.
Hafner C; López-Knowles E; Luis NM; Toll A; Baselga E; Fernández-Casado A; Hernández S; Ribé A; Mentzel T; Stoehr R; Hofstaedter F; Landthaler M; Vogt T; Pujol RM; Hartmann A; Real FX
Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13450-4. PubMed ID: 17673550
[TBL] [Abstract][Full Text] [Related]
17. Nonmelanoma skin cancers in association with seborrheic keratoses. Clinicopathologic correlations.
Maize JC; Snider RL
Dermatol Surg; 1995 Nov; 21(11):960-2. PubMed ID: 7582834
[TBL] [Abstract][Full Text] [Related]
18. Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours.
Hida Y; Kubo Y; Arase S
Br J Dermatol; 2009 Jun; 160(6):1258-63. PubMed ID: 19298285
[TBL] [Abstract][Full Text] [Related]
19. Two cases of seborrheic keratosis of the external ear canal: involvement of PIK3CA and FGFR3 genes.
De Loof M; Van Dorpe J; Van Der Meulen J; Lefever S; Dhooge I
Int J Dermatol; 2018 Jun; 57(6):703-706. PubMed ID: 29485181
[TBL] [Abstract][Full Text] [Related]
20. Sustained Akt Activity Is Required to Maintain Cell Viability in Seborrheic Keratosis, a Benign Epithelial Tumor.
Neel VA; Todorova K; Wang J; Kwon E; Kang M; Liu Q; Gray N; Lee SW; Mandinova A
J Invest Dermatol; 2016 Mar; 136(3):696-705. PubMed ID: 26739095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
